The safety of gliptins : updated data in 2018
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2018.1444027
Abstract: ABSTRACT Introduction: Dipeptidyl peptidase-4 inhibitors (DPP-4is) are generally considered as glucose-lowering agents with a safe profile in type 2 diabetes. Areas covered: An updated review of recent safety data from randomised controlled trials, observational studies,… read more here.
Keywords: gliptins updated; dpp 4is; safety; safety gliptins ... See more keywords